← Russell 3000 cross-section

ACHC Acadia Healthcare Company, Inc.

Trailing twelve months to 2026-03-31 · as filed 2026-04-30, not restated
Healthcare

Scale

Market cap
$2.8bn
Revenue TTM
$3.4bn
Net income TTM
$-1.1bn
Free cash flow
$-292m
Composite score
Sector rank
#1442

Valuation

P / E
EV / EBITDA
EV / sales
1.5
FCF yield
-10.46%
Earnings yield vs 10-yr
-44.43pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-32.8%
EBITDA margin
ROE
-56.5%
ROIC
Revenue growth
6.8%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Management expects to take advantage of several strategies that are more accessible as a result of our increased size and geographic scale, including continuing a national marketing strategy to attract new patients and referral sources, increasing our volume of out-of-state referrals, providing a broader range of services to new and existing patients and clients and selectively pursuing opportunities to expand our facility and bed count through acquisitions, wholly-owned de novo facilities, joint ventures and bed additions in existing facilities. Three months ended June 30, 2026 compared to the three months ended June 30, 2025 Revenue. …Acadia Healthcare Company, Inc., 10-Q, period ended 2026-06-30, filed 2026-07-28

Read the full passage →